The fibroblast growth factor signaling pathway

DM Ornitz, N Itoh - Wiley Interdisciplinary Reviews …, 2015 - Wiley Online Library
The signaling component of the mammalian Fibroblast Growth Factor (FGF) family is
comprised of eighteen secreted proteins that interact with four signaling tyrosine kinase FGF …

Targeting FGFR signaling in cancer

M Touat, E Ileana, S Postel-Vinay, F André… - Clinical cancer …, 2015 - AACR
The fibroblast growth factor signaling pathway (FGFR signaling) is an evolutionary
conserved signaling cascade that regulates several basic biologic processes, including …

[HTML][HTML] The role of the ALK receptor in cancer biology

B Hallberg, RH Palmer - Annals of Oncology, 2016 - Elsevier
ABSTRACT A vast array of oncogenic variants has been identified for anaplastic lymphoma
kinase (ALK). Therefore, there is a need to better understand the role of ALK in cancer …

Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

AM Schram, MT Chang, P Jonsson… - Nature reviews Clinical …, 2017 - nature.com
Structural gene rearrangements resulting in gene fusions are frequent events in solid
tumours. The identification of certain activating fusions can aid in the diagnosis and effective …

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

B Hallberg, RH Palmer - Nature Reviews Cancer, 2013 - nature.com
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many
cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer …

[HTML][HTML] Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

R Dienstmann, J Rodon, A Prat, J Perez-Garcia… - Annals of oncology, 2014 - Elsevier
The fibroblast growth factor receptor (FGFR) cascade plays crucial roles in tumor cell
proliferation, angiogenesis, migration and survival. Accumulating evidence suggests that in …

[HTML][HTML] Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

T Kohno, T Nakaoku, K Tsuta… - … lung cancer research, 2015 - ncbi.nlm.nih.gov
Fusions of the RET and ROS1 protein tyrosine kinase oncogenes with several partner genes
were recently identified as new targetable genetic aberrations in cases of non-small cell …

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

A Vaishnavi, M Capelletti, AT Le, S Kako, M Butaney… - Nature medicine, 2013 - nature.com
We identified new gene fusions in patients with lung cancer harboring the kinase domain of
the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein) …

Detection, characterization, and inhibition of FGFR–TACC fusions in IDH wild-type glioma

AL Di Stefano, A Fucci, V Frattini, M Labussiere… - Clinical cancer …, 2015 - AACR
Purpose: Oncogenic fusions consisting of fibroblast growth factor receptor (FGFR) and
TACC are present in a subgroup of glioblastoma (GBM) and other human cancers and have …

Tyrosine kinase gene rearrangements in epithelial malignancies

AT Shaw, PP Hsu, MM Awad, JA Engelman - Nature reviews Cancer, 2013 - nature.com
Chromosomal rearrangements that lead to oncogenic kinase activation are observed in
many epithelial cancers. These cancers express activated fusion kinases that drive the …